Title of article :
Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report
Author/Authors :
Salehi, Mohammadreza Imam Khomeini Complex Hospital - Department of Infectious Diseases - Tehran University of Medical Sciences, Tehran, Iran , Shahi,Farhad Department of Adult Hematology and Oncology - Imam Khomeini Complex Hospital - Tehran University of Medical Sciences, Tehran, Iran , Sadaat Rizvi, Fatema School of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Zainaldain, Hamed School of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Khodavaisy, Sadegh Department of Medical Mycology and Parasitology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Jamali-Moghaddam, Reza Ziaeian Hospital - Department of Infectious Diseases - Tehran University of Medical Sciences, Tehran, Iran , Dehghan Manshadi, Ali Imam Khomeini Complex Hospital - Department of Infectious Diseases - Tehran University of Medical Sciences, Tehran, Iran , Rezahosseini, Omid Imam Khomeini Complex Hospital - Department of Infectious Diseases - Tehran University of Medical Sciences, Tehran, Iran
Pages :
4
From page :
227
To page :
230
Abstract :
Mucormycosis is an uncommon fungal infection caused by the members of the order Mucorales. In susceptible patients, mucormycosis can infect any tissue or organ, and without suitable treatment (i.e., debridement and antifungal therapy), this infection can be fatal. Our patient was a woman with lymphoma and cerebral mucormycosis who was treated with antifungals and without any neurosurgical debridement. Case Presentation: Herein, we present the case of a 35-year-old woman with diagnosis of B-cell lymphoma and rhino-orbito-cerebral mucormycosis (ROCM). She was a candidate for enucleation of the left eye, orbital decompression, and sinocerebral debridement. Nevertheless, the patient refused eye enucleation and craniotomy. Finally, she was treated with a combination of antifungals and sinus debridement without eye enucleation and craniotomy. Conclusion: Endoscopic debridement, along with a combination of liposomal amphotericin B (LAMB) and posaconazole, may be a suitable therapeutic option for patients with ROCM, who are not eligible candidates for extensive surgery or craniotomy.
Keywords :
Posaconazole , Mucormycosis , Invasive fungal infection , Combination drug therapies , Liposomal amphotericin B
Journal title :
Caspian Journal of Internal Medicine (CJIM)
Serial Year :
2020
Record number :
2631359
Link To Document :
بازگشت